ロード中...
Biological frontiers in multiple myeloma: From biomarker identification to clinical practice
Since the mid-1990s, the multiple myeloma (MM) treatment landscape has evolved considerably, which has led to improved patient outcomes and prolonged survival. In addition to discovering new, targeted agents or treatment regimens, the identification and validation of biomarkers has the potential to...
保存先:
| 出版年: | Clin Cancer Res |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2013
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5576179/ https://ncbi.nlm.nih.gov/pubmed/24270684 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-13-2159 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|